Consolidated Statement of Changes in Equity (Unaudited) - USD ($) $ in Thousands	Total		Cumulative Effect of Adoption of ASU 2016-13	Series A Preferred Stock	Series C Preferred Stock	Series B Preferred Stock	Class A Common Stock	Common Stock	Additional Paid-in-Capital	Accumulated Deficit	Accumulated Deficit Cumulative Effect of Adoption of ASU 2016-13	Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2019	$ 1,503,954		$ (19,645)				$ 1	$ 75	$ 1,530,935	$ (28,108)	$ (19,645)	$ 1,051
Balance, Shares at Dec. 31, 2019				125			1,136,665	74,886,113
Accounting Standards Update Extensible List			ASU 2016-13
Issuance of Common Stock	12,895							$ 1	12,894
Issuance of Common Stock, Shares								628,218
Conversions of Class A Common Stock to Common Stock							$ (1)	$ 1
Conversions of Class A Common Stock to Common Stock, Shares							(1,136,665)	1,136,665
Equity Issuance, Shelf Registration, and Equity Distribution Agreement Transaction Costs	(206)								(206)
Amortization of Share-Based Compensation	1,401								1,401
Net Income (Loss)	(232,790)									(232,790)
Other Comprehensive Loss	(974)											(974)
Dividends on Preferred Stock	(3)									(3)
Dividends on Common Stock (Dividends Declared per Share)	(33,219)									(33,219)
Balance at Mar. 31, 2020	1,231,413							$ 77	1,545,024	(313,765)		77
Balance, Shares at Mar. 31, 2020				125				76,650,996
Balance at Dec. 31, 2019	1,503,954		$ (19,645)				$ 1	$ 75	1,530,935	(28,108)	$ (19,645)	1,051
Balance, Shares at Dec. 31, 2019				125			1,136,665	74,886,113
Net Income (Loss)	(189,862)
Balance at Jun. 30, 2020	1,271,221							$ 77	1,559,684	(288,540)
Balance, Shares at Jun. 30, 2020				125				76,792,432
Temporary Equity, Balance at Jun. 30, 2020						$ 196,832
Balance at Mar. 31, 2020	1,231,413							$ 77	1,545,024	(313,765)		77
Balance, Shares at Mar. 31, 2020				125				76,650,996
Temporary Equity, Issuance of Series B Preferred Stock						225,000
Series B Preferred Stock Allocated Warrant Fair Value to Purchase Common Stock	14,402								14,402
Temporary Equity, Series B Preferred Stock Allocated Warrant Fair Value to Purchase Common Stock						(14,402)
Issuance of Common Stock, Shares								160,278
Retirement of Common Stock, Shares								(18,842)
Equity Issuance, Shelf Registration, and Equity Distribution Agreement Transaction Costs	(985)								(985)
Temporary Equity, Equity Issuance, Shelf Registration, and Equity Distribution Agreement Transaction Costs						(14,209)
Amortization of Share-Based Compensation	1,686								1,686
Net Income (Loss)	42,928									42,928
Other Comprehensive Loss	(77)											$ (77)
Dividends on Preferred Stock	(2,255)									(2,255)
Series B Preferred Stock Accretion and Write-off of Discount, including Allocated Warrant Fair Value and Transaction Costs	(443)								(443)
Temporary Equity, Series B Preferred Stock Accretion and Write-off of Discount, including Allocated Warrant Fair Value and Transaction Costs						443
Dividends on Common Stock (Dividends Declared per Share)	(15,448)									(15,448)
Balance at Jun. 30, 2020	1,271,221							$ 77	1,559,684	(288,540)
Balance, Shares at Jun. 30, 2020				125				76,792,432
Temporary Equity, Balance at Jun. 30, 2020						196,832
Balance at Dec. 31, 2020	1,266,900	[1]						$ 77	1,559,681	(292,858)
Balance, Shares at Dec. 31, 2020				125				76,787,006
Temporary Equity, Balance at Dec. 31, 2020						199,551
Issuance of Common Stock, Shares								110,096
Amortization of Share-Based Compensation	1,456								1,456
Net Income (Loss)	31,955									31,955
Dividends on Preferred Stock	(6,124)									(6,124)
Series B Preferred Stock Accretion and Write-off of Discount, including Allocated Warrant Fair Value and Transaction Costs	(1,452)								(1,452)
Temporary Equity, Series B Preferred Stock Accretion and Write-off of Discount, including Allocated Warrant Fair Value and Transaction Costs						1,452
Dividends on Common Stock (Dividends Declared per Share)	(15,507)									(15,507)
Balance at Mar. 31, 2021	1,277,228							$ 77	1,559,685	(282,534)
Balance, Shares at Mar. 31, 2021				125				76,897,102
Temporary Equity, Balance at Mar. 31, 2021						201,003
Balance at Dec. 31, 2020	1,266,900	[1]						$ 77	1,559,681	(292,858)
Balance, Shares at Dec. 31, 2020				125				76,787,006
Temporary Equity, Balance at Dec. 31, 2020						199,551
Net Income (Loss)	64,347
Balance at Jun. 30, 2021	1,437,191	[1]			$ 8			$ 77	1,708,972	(271,866)
Balance, Shares at Jun. 30, 2021				125	8,050,000			77,089,125
Balance at Mar. 31, 2021	1,277,228							$ 77	1,559,685	(282,534)
Balance, Shares at Mar. 31, 2021				125				76,897,102
Temporary Equity, Balance at Mar. 31, 2021						201,003
Issuance of Common Stock, Shares								192,023
Issuance of Series C Preferred Stock	201,250				$ 8				201,242
Issuance of Series C Preferred Stock, Shares					8,050,000
Equity Issuance, Shelf Registration, and Equity Distribution Agreement Transaction Costs	(6,866)								(6,866)
Amortization of Share-Based Compensation	1,393								1,393
Net Income (Loss)	32,391									32,391
Dividends on Preferred Stock	(6,214)									(6,214)
Series B Preferred Stock Redemption at Par Value						(225,000)
Series B Preferred Stock Redemption Make-Whole Payment	(22,485)								(22,485)
Series B Preferred Stock Accretion and Write-off of Discount, including Allocated Warrant Fair Value and Transaction Costs	(23,997)								(23,997)
Temporary Equity, Series B Preferred Stock Accretion and Write-off of Discount, including Allocated Warrant Fair Value and Transaction Costs						$ 23,997
Dividends on Common Stock (Dividends Declared per Share)	(15,509)									(15,509)
Balance at Jun. 30, 2021	$ 1,437,191	[1]			$ 8			$ 77	$ 1,708,972	$ (271,866)
Balance, Shares at Jun. 30, 2021				125	8,050,000			77,089,125

[1] The Company’s consolidated Total Assets and Total Liabilities as of June 30, 2021 include assets and liabilities of variable interest entities (“VIEs”) of $3.4 billion and $2.8 billion, respectively. The Company’s consolidated Total Assets and Total Liabilities as of December 31, 2020 include assets and liabilities of VIEs of $2.3 billion and $1.8 billion, respectively. These assets can be used only to satisfy obligations of the VIEs, and creditors of the VIEs have recourse only to these assets, and not to TPG RE Finance Trust, Inc. See Note 6 to the Consolidated Financial Statements for details